CompletedPhase 3NCT02342184
Efficacy and Safety Study of GB-0998 for Guillain-Barré Syndrome
Studying Acute inflammatory demyelinating polyradiculoneuropathy
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Japan Blood Products Organization
- Principal Investigator
- Kyoichi NomuraDepartment of Neurology, Saitama Medical Center, Saitama Medical University, Saitama, Japan
- Intervention
- GB-0998(drug)
- Enrollment
- 21 enrolled
- Eligibility
- 16 years · All sexes
- Timeline
- 2014 – 2015
Study locations (1)
- Department of Neurology, Saitama Medical Center, Saitama Medical University, Kawagoe, Saitama, Japan
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT02342184 on ClinicalTrials.govOther trials for Acute inflammatory demyelinating polyradiculoneuropathy
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT06822231High-Tech Rehabilitation Pathway for Acute Adult Neuromuscular Diseases - Fit4MedRob-Acute MND ProjectIstituti Clinici Scientifici Maugeri SpA
- ACTIVE NOT RECRUITINGPHASE4NCT06620198Upper Limb Robot-Assisted Therapy in Patients with Guillain-Barré SyndromeI.R.C.C.S. Fondazione Santa Lucia
- RECRUITINGNCT06615622Our Study Aims to Determine if Nerve Alterations in Acute GBS and CIDP Detectable by Ultrasound Match Electrodiagnostic Findings and if This Method Aids Early Diagnosis, Predict Their Outcomes and Differentiate Between Axonal and Demyelinating Subtypes.Assiut University
- RECRUITINGNANCT05461898RehabGBs: Rehabilitation in People With Guillain-Barré SyndromeCentro de Reabilitacao do Norte
See all trials for Acute inflammatory demyelinating polyradiculoneuropathy →